Bioresonance, an alternative therapy for mild and moderate depression

Citation. Muresan D, Voidăzan S, Salcudean A, Bodo CR, Grecu IG (2022). Bioresonance, an alternative therapy for mild and moderate depression. Experimental and Therapeutic Medicine 23(4):264. PMID 35251330.

Study type and size. Two-group comparison versus SSRI monotherapy, not randomised. Sample: not stated in the abstract.

What the paper reports. Mean Hamilton depression score change of 3.1 (bioresonance) versus 2.2 (SSRI), p<0.0001. Overlaps the group’s 2021 dataset.

Read the original. https://doi.org/10.3892/etm.2022.11190

This entry describes what the authors report. It is not a claim by this site that bioresonance diagnoses or treats any condition.

David Franklin

David Franklin is an advocate of Bioresonance therapy. He has seen how this form of treatment has helped his wife Sarah, who suffers from Addisons disease. David supplies Bicom Optima devices to therapists all over the world, and he also trains them on how to use the medical equipment effectively.

See Full Bio